@FierceBiotech: Open source sizzles in biotech sphere. More | Follow @FierceBiotech
@JohnCFierce: No surprise AZ is talking up brewing up more deals this year. No surprise they aren't even sticking to their disease focus. | Follow @JohnCFierce
@RyanMFierce: FDA CIO Eric Perakslis told me that he wants to enable certain agency staff to work more virtually. He's giving more details at Bio-IT World 2012. | Follow @RyanMFierce
@MarkHFierce: Seeking healthy fat? Then clone a sheep with the right nutrients genetically woven in--via Reuters. Article | Follow @MarkHFierce
> Life Technologies ($LIFE) is budgeting $20 million to expand its cell culture manufacturing facilities in Scotland. Release
> Novartis ($NVS) and Vectura posted more positive late-stage data for their COPD drug QVA149, showing it was superior to GlaxoSmithKline's ($GSK) Seretide. But analysts at Barclays zeroed in on the positive implications for GSK's own rival to QVA149. Story
> Ikaria says Australian regulators have approved Lucassin for HRS 1 patients considered for a liver transplant. Release
Pharma News
@FiercePharma: More on Novartis' Q2 results, from Bloomberg. Consumer sales tumble 20% on plant closure. News | Follow @FiercePharma
> Diovan rivals, plant woes pinch Novartis profits. Article
> Novartis wants U.K. to quash off-label Avastin use. More
> Watson set to unveil $5.9B Actavis buy, FT reports. Item
Medical Devices News
@FierceMedDev: Orthofix to sell sports-medicine unit for $157.5M | MarketWatch. Story | Follow @FierceMedDev
> Boston Sci heralds Emerge launch in Europe, eyes U.S., other markets. Article
> Illumina results impress despite Roche drama. News
> Orthofix to sell sports medicine unit for $157.5M. Report
Biotech Research News
> Powerful protein halts DNA damage and may block tumors. More
> Johns Hopkins researchers find gene tied to CF secondary complication. Article
> Beyond stem cells: Scientists explore three new paths. Story
> Scientists successfully replicate synthetic DNA. Item
> Nanotech-boosted drug lessens cerebral palsy symptoms in rabbits. News
Pharma Manufacturing News
> Alli sale still held hostage by Roche GMP issues. Item
> Life Technologies expands manufacturing in Scotland. More
> China seizes 77 million tainted drug capsules in crackdown. News
> Merck KGaA manufacturing dodges worst of reductions. Article
> Pfizer, J&J, Abbott facing shortages of crucial ingredients in Pakistan. Story
And Finally… A team of Canadian investigators say that anti-depressants appear to do more harm than good. Release